About: Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.20 (-9.77%)
GUTS NASDAQ Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock share price
Atividade de preço de GUTS
Último preço
$ 1,200
Variação (24h)
-0,13 USD (9,77%)
Volume
794.54K
Volume (média 4 sem.)
-
Abertura
$ 1,36
Variação do dia
$ 1,11 - $ 1,37
Fechamento anterior
$ 1,33
Último negócio
21 Oct, 5:20 pm GMT+0
Atrasado
21 Oct, 5:20 pm GMT+0
GUTS price performance
Atrasado
21 Oct, 5:20 pm GMT+0
quote.marketSignals